Gynecology Ultrasound Systems in Pennsylvania

Halo Medical Technologies designs and manufactures high-resolution 2D/3D multicompartment ultrasound systems specialized in anorectal and pelvic floor imaging. Founded by pelvic floor experts, the company delivers the Catalyst Ultrasound Systems line, available in both compact and conventional configurations to suit space-constrained and high-volume clinical environments. Core imaging modalities include endoanal, transrectal, endovaginal, and transperineal approaches. The systems feature innovative software-guided workflows, 60-second video capture and replay capability, still-image freeze-frame functionality, and auto-generated EMR-ready reports with auto-populated measurements and interpretations. Clinical indications addressed include defecation disorders, pelvic floor dysfunction, fistulas, benign and malignant disease, prolapse, sling detection and management, and dynamic ultrasound assessment. Halo also manufactures specialized ultrasound probes designed for pelvic floor applications. The company provides complementary clinical resources including the Atlas of Images—a comprehensive library of over 150 pages of pelvic floor ultrasound imagery, diagrams, videos, and educational content available online and in PDF form. Support materials include instructions for use (IFU), CPT coding guidance, patient questionnaires, and technical documentation. Target markets include urogynecologists, colorectal surgeons, gastroenterologists, and female urologists. The company emphasizes affordability and clinical utility in its product design philosophy.

UE LifeSciences Inc. is a medical device innovator focused on accessible, hand-held diagnostic solutions for early cancer detection in resource-limited and low-income settings. The company develops non-invasive, radiation-free, pain-free screening devices operable by community health workers with minimal training and offline capability, enabling instant results with validated high efficacy. Their product portfolio addresses breast, cervical, and oral cancer screening—the leading cancer burdens in underserved populations globally. iBreastExam is an extensively validated handheld breast lump detection device; cervAIcal is a mobile colposcope for cervical cancer assessment; OrCA addresses oral cancer screening. RaKSA is a multi-cancer screening navigation initiative integrating breast, cervical, and oral examination into single-visit protocols for large-scale implementation. The company has supplied over 2 million breast exams, detected 500+ cancers, and operates in 10 markets across USA, India, Malaysia, Colombia, and Thailand. UE LifeSciences partners with HLL Lifecare (India), major imaging-diagnostics firms, and regional pharma and diagnostics distributors. The company has raised $8.5M in capital, secured $1.7M+ in grants, and earned 15+ awards. Featured in The New York Times, BBC News, Forbes, and TED Talks, UE LifeSciences targets primary and secondary care providers, government health programs, NGOs, and private healthcare networks seeking equitable early detection infrastructure.